Occurrence of the antidiabetic drug Metformin and its ultimate transformation product Guanylurea in several compartments of the aquatic cycle

摘要

In 2030, the World Health Organization estimates that more than 350 million people will be diagnosed with diabetes. Consequently, Metformin - the biguanide drug of choice orally administered for diabetes type Ⅱ - is anticipated to see a spike in production. Unlike many pharmaceutical drugs, Metformin (Met) is not metabolized by humans but passes through the body unchanged. Entering aquatic compartments, such as in sewage, it can be bacterially transformed to the ultimate transformation product Guanylurea (Gua). Sampling over one week (n = 5) from a Southern German sewage treatment plant revealed very high average (AV) concentrations in influent (AV_(Met) = 111,800 ng/L, AV_(Gua) = 1300 ng/L) and effluent samples (AV_(Met) = 4800 ng/L, AV_(Gua) = 44,000 ng/L). To provide a more complete picture of the distribution and potential persistence of these compounds in the German water cycle, a new, efficient and highly sensitive liquid chromatography mass spectrometric method with direct injection was used for the measurement of Metformin and Guanylurea in drinking, surface, sewage and seawater. Limits of quantification (LOQ) ranging from 2-10 ng/L allowed the detection of Metformin and Guanylurea in different locations such as: Lake Constance (n = 11: AV_(Met) =102 ng/L, AV_(Gua) =16 ng/L), river Elbe (n = 12: AV_(Met) = 472 ng/L, AV_(Gua) = 9 ng/L), river Weser (n = 6: AV_(Met) = 349 ng/L, AV_(Gua) = 137 ng/L) and for the first time in marine North Sea water (n = 14: AV_(Met) =13 ng/L, AV_(Gua) =11 ng/L). Based on daily water discharges, Metformin loads of 15.2 kg/d (Elbe) and 6.4 kg/d (Weser) into the North Sea were calculated. Lake Constance is used to abstract potable water which is further purified to be used as drinking water. A first screening of two tap water samples contained 2 ng/L and 61 ng/L of Metformin, respectively. The results of this study suggest that Metformin and Guanylurea could be distributed over a large fraction of the world's potable water sources and oceans. With no natural degradation processes, these compounds can be easily reintroduced to humans as they enter the food chain.